Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Gina Sanchez, Lido Advisors chief market strategist, joins CNBC's 'The Exchange' to discuss these stocks: Microsoft, Eli ...

Eli Lilly reported third-quarter earnings and revenue below Wall Street expectations, reducing its full-year adjusted profit ...

A new investigation found that such medicines can reduce the risk of Alzheimer ... The implications of this study are tremendous for both Eli Lilly and Novo Nordisk, as both already have blockbuster ...

Over the last month, Dell and Super Micro have been sparring in the headlines with new product releases. Just two weeks ago, ...

Excluding items, Eli Lilly And Co. reported adjusted earnings ... author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with ...

Leerink Partners analyst David Risinger has maintained their bullish stance on LLY stock, giving a Buy rating today. David Risinger’s ...

Eli Lilly, meanwhile, tested its IL-13 inhibitor ... The phase 3b ADapt study found that 57% of patients on Lilly’s drug achieved a 75% or greater improvement in their Eczema Area and Severity ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

For Eli Lilly, this appointment is bullish ... it's very likely that Fuchs is qualified for the job. He founded an AI company and holds a PhD in machine learning, and he was the dean of AI ...